Drug Topics

JUNE 20, 2025

With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.

Vaccines

Drug Topics

JULY 18, 2025

The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.

Vaccines

Pharmacy Times

JUNE 24, 2025

What I like about this conference is it's pharmacists pulling out the abstracts, it's pharmacists presenting the abstracts, and it's a panel discussion of that abstract by pharmacists. So it's ASCO from a pharmacist perspective. And I like that. It's disease-state focused.

Compounding Pharmacies

Pharmacy Times

JULY 16, 2025

Hematologic malignancy presentations brought long-term evidence of benefit with Bruton tyrosine kinase (BTK) inhibitors and BCL2 combinations in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and promising early-phase results for T-cell engagers (TCEs) in myeloma and lymphoma.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

When you are enjoyable to work with, reliable, organized, and do impactful work, your name often comes up in spaces where you’re not present, opening doors to new partnerships. Strong collaborations lead to opportunities. It’s a cycle of trust and shared success, and I’ve been fortunate to benefit from and contribute to it.

Compounding Pharmacies

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition. Things are too serious.”

Community Pharmacies

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Pharmacy Times

JULY 2, 2025

Ototoxicity, presenting as tinnitus, hearing loss, dizziness, or vertigo, could occur and can be reversible or permanent. The study authors noted that sepsis is also a leading cause of death and hospitalization that often requires antibiotic administration.

FDA

Pharmacy Times

JUNE 20, 2025

She also discusses HOPA and its partnership with Pharmacy Times in providing cutting-edge information, expressing admiration for the Oncology Pharmacist Connect (OPC) conference's rapid dissemination of relevant information and high-quality presentations. Pharmacy Times : Can you discuss your career experience as an oncology pharmacist?

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing. The lack of access to immunization services may lead to lower vaccination rates and vulnerabilities to infectious diseases in these communities.

Mail-Order Pharmacies

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Compounding Pharmacies

Pharmacy Times

JUNE 9, 2025

These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology.

Chemotherapy

Pharmacy Times

JUNE 27, 2025

Patients often present with peripheral blood, bone marrow, and splenic involvement. Leukemic nonnodal MCL , in contrast, originates from B cells that have undergone germinal center passage with somatic hypermutation in IGHV and that lack SOX11 expression. This subtype is associated with a more indolent course and genomic stability over time.

FDA

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider.

Patient Care

Pharmacy Times

JUNE 12, 2025

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care.

Compounding Pharmacies

Pharmacy Times

JUNE 20, 2025

SHOW MORE When no contraindications are present, most cases can be managed well with nonsteroidal anti-inflammatory drugs. Pharmacists are essential in guiding treatment, identifying contraindications, and advising when further medical evaluation is needed.

Compounding Pharmacies

Drug Topics

JULY 17, 2025

The goal of the researchers’ study was to present the potential impact that pharmacist-led interventions and counseling can have for patients struggling with the condition. With pharmacist-led interventions and care increasingly on the rise, researchers explored them in the context of COPD management.

Specialty Pharmacies

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.

Compounding Pharmacies

Pharmacy Times

JUNE 13, 2025

During the session “Collaborative Practice, Statewide Protocols, and Independent Prescriptive Authority: How Pharmacy is Expanding Services to Increase Access to Patients,” Klepser highlighted the importance of moving beyond product dispensing to provide higher-level services, such as immunizations and medication therapy management.

Compounding Pharmacies

Pharmacy Times

JULY 12, 2025

4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management. Addressing Barriers and Finding Solutions Despite the promise of these services, challenges remain.

Independent Pharmacies

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Immunization

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. The results confirm nemolizumab’s use in increasing improvements in symptoms, such as itch and skin lesions, with prolonged treatment up to 2 years.

Compounding Pharmacies

Drug Topics

JULY 7, 2025

link] Recent Videos Related Content Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information Ashley Gallagher ; Laura Knockel, PharmD, BCACP July 6th 2025 Article Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Mail-Order Pharmacies

Pharmacy Times

JULY 19, 2025

While the results of this study were presented at the American College of Cardiology meeting in 2023, the completed study results have yet to be published. In a second phase 2 trial using the same dose regimens of baxdrostat in resistant hypertension, placebo-subtracted reductions were not statistically significant.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. AON Pharmacy's interventions saved $1.9 million by withholding shipments due to therapy changes or patient status.

Mail-Order Pharmacies

Pharmacy Times

JUNE 11, 2025

Fertility preservation remains a critical yet often overlooked component of comprehensive cancer care, especially among patients of reproductive age.

Specialty Pharmacies

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What are some key sessions that will be presented at the upcoming 2025 ADA Scientific Sessions? I'm an endocrine pharmacist and director of education and training and diabetes technology at the Cleveland Clinic. Isaacs : I am so excited for the ADA Scientific Sessions. It is my favorite meeting of the entire year.

Compounding Pharmacies

Pharmacy Times

JUNE 12, 2025

The session, which was entitled “Decoding the Logic: An Overview of Biologics and Biosimilars,” described clinical applications and economic impacts associated with biologics and biosimilars over the last 10 to 15 years, as well as outlined what skills effectively contribute to their management and understanding.

Immunization

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? Heidi Finnes, PharmD, BCOP, FHOPA : I shared new hope in cutaneous malignancies and abstracts from the 2025 ASCO meeting. Pharmacy Times : What challenges currently exist in the treatment of cutaneous malignancies?

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

Alixorexton presents as a hopeful, potentially paradigm-shifting treatment for this population. OX2Rs play a critical role in the maintenance of wakefulness in patients with NT1, which is characterized by the loss of orexin-producing neurons in cerebrospinal fluid.

Compounding Pharmacies

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting.

Specialty Pharmacies

Pharmacy Times

JUNE 26, 2025

The findings, published in The New England Journal of Medicine and presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois, demonstrated that 10 of the 12 treated individuals no longer needed insulin treatment in a 1-year follow-up.

Compounding Pharmacies

Pharmacy Times

JUNE 23, 2025

Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. If the request doesn’t come in, all 505(b)(2) drugs will be considered nontherapeutically equivalent and therefore get their own J-code. That’s the system we are headed into very rapidly.” REFERENCE Soefje SA.

FDA

Pharmacy Times

JULY 23, 2025

Understanding and addressing these emotional barriers may present an opportunity to improve adherence and long-term engagement. For patients beginning treatment with immunology biologics or other specialty medications, the transition can be daunting, involving new routines, adverse effect concerns, and evolving perceptions of illness.

Specialty Pharmacies

Pharmacy Times

JULY 31, 2025

Despite reduced prevalence of targeted serotypes, vaccine serotypes persist, necessitating future vaccine development. Resistance to sulfonamides, lincosamides, and penicillin was observed across numerous pneumococcal serotypes.

Vaccines

Drug Topics

JULY 24, 2025

Kennedy Jr signed to adopt the CDC's Advisory Committee on Immunization Practices (ACIP) recommendations to remove mercury-based thimerosal from all influenza vaccines distributed in the United States. In a vote of 5 to 1 in June 2025, ACIP voted to recommend against influenza vaccines containing the preservative thimerosal.

Specialty Pharmacies

Pharmacy Times

JULY 9, 2025

However, patients with CLL/SLL typically have a higher risk of serious infection due to their compromised immune systems, raising concerns about the association between CLL/SLL-directed therapies and serious infection risks.

Immunization